MapLight Therapeutics Funding & Investors
Palo Alto, CA
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
maplightrx.comTotal Amount Raised: $640,600,000
MapLight Therapeutics Funding Rounds
Series D
$372,500,000
Series D Investors
Forbion Capital PartnersGoldman Sachs AlternativesNovo HoldingsSanofi-Aventis5am VenturesBlue OwlAvego Bioscience CapitalT. Rowe PriceSeries C
$225,000,000
Series C Investors
5am VenturesCowenNovo HoldingsSeries Unknown
$29,999,999
Grant
$8,100,000
Grant Investors
The Michael J. Fox Foundation for Parkinson's ResearchSeries Unknown
$5,000,000
Funding info provided by Diffbot.